VNDA Vanda Pharmaceuticals Inc

4.255
-0.105 (-2.41%)
Last Updated: 12:24:33
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

Period:

Draw Mode:

Volume 261,084
Bid Price 4.25
Ask Price 4.26
News -
Day High 4.41

Low
4.15

52 Week Range

High
11.0425

Day Low 4.23
Company Name Stock Ticker Symbol Market Type
Vanda Pharmaceuticals Inc VNDA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.105 -2.41% 4.255 12:24:33
Open Price Low Price High Price Close Price Prev Close
4.35 4.23 4.41 4.36
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,105 261,084 $ 4.30 $ 1,123,817 - 4.15 - 11.0425
Last Trade Time Type Quantity Stock Price Currency
12:27:34 10 $ 4.255 USD

Vanda Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
244.7M 57.51M - 254.38M 6.28M 0.00 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Vanda Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No VNDA Message Board. Create One! See More Posts on VNDA Message Board See More Message Board Posts

Historical VNDA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.464.694.234.521,030,773-0.205-4.6%
1 Month5.215.3554.154.602,455,003-0.955-18.33%
3 Months6.566.714.155.051,179,565-2.31-35.14%
6 Months6.817.004.155.54850,769-2.56-37.52%
1 Year9.7911.04254.156.49717,253-5.54-56.54%
3 Years9.3421.86274.1511.03561,335-5.09-54.44%
5 Years22.9633.444.1513.18606,302-18.71-81.47%

Vanda Pharmaceuticals Description

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improves the lives of patients. Its commercial portfolio comprises two products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) and Fanapt for the treatment of schizophrenia. Its other products include Tradipitant (VLY-686), VTR-297, and VQW-765.
Your Recent History
NASDAQ
VNDA
Vanda Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now